While a nested case-control study by Taipale et al. has reported a significant association between long-term exposition to prolactin-increasing antipsychotics and increased odds of breast cancer [20], other research suggests that antipsychotic drugs overall may hold potent anti-cancer properties. Here, PRL is linked to breast carcinoma.